Former CDC Director Calls for Removal of mRNA Vaccines for COVID-19 | Dr. Robert Redfield

Dr. Robert Redfield, former director of the Centers for Disease Control and Prevention, says he’d like to see the mRNA COVID-19 vaccines phased out and eventually removed from the market.

Redfield led the CDC from 2018 to 2021. While an avid proponent of vaccines in general, he hopes that the fallout from the emergency-authorized mRNA vaccines will lead to a broader recognition that vaccine manufacturers must no longer be exempt from liability.

Redfield is a clinical virologist who, prior to his appointment as CDC director in 2018, spent decades in HIV/AIDS research and clinical care, including service in the U.S. Army Medical Corps and later at the University of Maryland, where he co-founded the Institute of Human Virology.

Over the past few years, he’s been at the forefront of treating patients who were injured by the mRNA COVID-19 vaccines.

In my interview with him, we covered at length the many hot topics and questions surrounding the recent pandemic and our pandemic response, among them:

How and why was the true origin of SARS-COV-2 suppressed? What indicators were there early on that the virus was likely leaked from a lab? What did Dr. Redfield know from classified documents at the beginning of 2020?

What were the most significant missteps America made in its response to the pandemic?

Is there a role for gain-of-function research in America? Or should it be outlawed?

What is the future of mRNA technology? Should mRNA technology be used for vaccines at all?

Why weren’t the vaccine-injured publicly acknowledged and adequately cared for?

What kinds of reforms are needed in America’s public health system?

Redfield’s new book is titled “Redfield’s Warning: What I Learned (but Couldn’t Tell You) Might Save Your Life.”

He argues a lab-created bird flu may be the next pandemic. But are we prepared?

Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.